Coral Laboratories Limited (BOM:524506)

India flag India · Delayed Price · Currency is INR
588.90
+12.50 (2.17%)
At close: Jul 9, 2026
Market Cap2.14B +0.9%
Revenue (ttm)859.00M -25.3%
Net Income163.81M -32.2%
EPS45.85 -32.2%
Shares Out 3.57M
PE Ratio13.08
Forward PEn/a
Dividend2.00 (0.33%)
Ex-Dividend Daten/a
Volume370
Open603.00
Previous Close576.40
Day's Range585.00 - 603.00
52-Week Range360.00 - 659.00
Beta0.84
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2026

About Coral Laboratories

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally. The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, ora... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 197
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524506
Full Company Profile

Financial Performance

In fiscal year 2026, Coral Laboratories's revenue was 859.00 million, a decrease of -25.31% compared to the previous year's 1.15 billion. Earnings were 163.81 million, a decrease of -32.18%.

Financial Statements